CHRISTELLA GUZMAN: Open Payments
NPI 1851480701 · HONOLULU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$494 in 16 payments from 7 companies in 2025. Trend: 2023 $1,230 · 2024 $1,121 · 2025 $494
Food & beverage: $494
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $169 |
| Novartis Pharmaceuticals Corporation | 5 | $152 |
| DePuy Synthes Sales Inc. | 2 | $58 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| Boston Scientific Corporation | 1 | $34 |
| Solventum Corporation | 1 | $25 |
| ABIOMED | 1 | $20 |
Products named: LEQVIO, EVENITY, MATRIXRIB, JARDIANCE, WATCHMAN FLX, PREVENA, REPATHA.
Industry payments across HI — which companies pay providers there.
